GL1X · GenesisL1 explorer

Research workbench

The identification, analysis and structure-based development of novel inhibitors of 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase

Analyse The identification, analysis and structure-based development of novel… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4M5N
Type
protein
Length
320 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase
EC
2.7.6.3
UniProt
P26281
Ligands
APC, YH7, MG
Pockets
3 · best druggability 0.74

Structure

x-ray diffraction · 1 distinct chain · 29% helix, 27% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, B2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase (EC 2.7.6.3)protein16029% helix, 27% strandP26281

Ligands and binding sites

  • APC · Diphosphomethylphosphonic acid adenosyl ester · ligand · 2 copies · chains A, B
  • YH7 · 6-amino-1,9-dihydro-2H-purine-2-thione · ligand · 2 copies · chains A, B
  • MG · Magnesium ion · metal · 4 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15420.740.8253MG, APC, YH7
23740.670.8142MG, APC, YH7
3510.450.8415empty

Interfaces

1 interface between chains.

  • A–B · 656 Ų buried · 12 hydrogen bonds · protein-protein

Compared structures

  • 4M5N · The Identification, Analysis and Structure-Based Development of Novel Inhibitors of… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.